Achieve Life Sciences (ACHV) Misses Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts ACHV Hot Sheet
Join SI Premium – FREE
Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($1.08), $0.27 worse than the analyst estimate of ($0.81).
For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Crown Crafts (CRWS) Reports Q4 EPS of $0.03
- FDA rejects Achieve Life Sciences drug application over manufacturing issues
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
